Filing Details

Accession Number:
0001209191-21-043495
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-28 16:52:50
Reporting Period:
2021-06-25
Accepted Time:
2021-06-28 16:52:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1237831 Globus Medical Inc GMED Surgical & Medical Instruments & Apparatus (3841) 043744954
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1752014 W Keith Pfeil Valley Forge Business Center
2560 General Armistead Avenue
Audubon PA 19403
Svp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-06-25 13,312 $49.65 13,312 No 4 M Direct
Class A Common Stock Acquisiton 2021-06-25 14,167 $53.27 14,167 No 4 M Direct
Class A Common Stock Disposition 2021-06-25 27,479 $75.04 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Stock Option (Right to Buy Class A Common Stock) Disposition 2021-06-25 13,312 $0.00 13,312 $49.65
Class A Common Stock Stock Option (Right to Buy Class A Common Stock) Disposition 2021-06-25 14,167 $0.00 14,167 $53.27
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,667 2029-09-03 No 4 M Direct
25,833 2030-01-22 No 4 M Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.25, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
  3. These options were granted on September 3, 2019, and vest over a four-year period with one-fourth (1/4) of the options vesting on August 19, 2020 and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  4. These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.